NCT01767363View on ClinicalTrials.gov

WEUSKOP5723: Prostate Cancer Study

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Prostatic Hyperplasia
Interventions
OTHER

5-alpha reductase inhibitors

Use of 5-alpha reductase inhibitors over the course of the study period.

OTHER

Alpha-blockers

Use of alpha-blockers over the study period.

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY